Lipid Peroxidation and Altered Antioxidant Profiles with Pediatric HIV Infection and Antiretroviral Therapy in Addis Ababa, Ethiopia

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Tropical Pediatrics

• Publication date

  2017-06-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1093/tropej/fmw076PMID 27940963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dawn of antioxidants and immune modulators to stop HIV-progression and boost the immune system in HIV/AIDS patients: An updated comprehensive and critical review

  2015cited by this paper
• Long-term Safety and Efficacy of Atazanavir-based Therapy in HIV-infected Infants, Children and Adolescents: The Pediatric AIDS Clinical Trials Group Protocol 1020A

  2015cited by this paper
• Serum hepcidin levels in women infected with HIV‐1 under antiviral therapy

  2014cited by this paper
• Substantial Effect of Efavirenz Monotherapy on Bilirubin Levels in Healthy Volunteers

  2014cited by this paper
• Serum Micronutrient Status of Haart-Naïve, HIV Infected Children in South Western Nigeria: A Case Controlled Study

  2014cited by this paper
• Oxidative Stress Mechanisms and their Modulation

  2014cited by this paper
• Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon

  2013cited by this paper
• Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy

  2013cited by this paper
• Oxidative Stress and Serum Selenium in HIV Patients on Different Antiretroviral Regimen

  2012cited by this paper
• Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV‐infected adults on stable antiretroviral therapy

  2012cited by this paper
• Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers.

  2012cited by this paper
• Increased oxidative stress condition found in different stages of HIV disease in patients undergoing antiretroviral therapy in Umuahia (Nigeria)

  2012cited by this paper
• Unexpected drug-drug interactions in human immunodeficiency virus (HIV) therapy: induction of UGT1A1 and bile efflux transporters by Efavirenz.

  2012cited by this paper
• Correlation of Selenium and Zinc Levels to Antiretroviral Treatment Outcomes in Thai HIV-infected Children without Severe HIV Symptoms

  2012cited by this paper
• Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial.

  2012cited by this paper
• Simple and Rapid Method for the Determination of Uric Acid-Independent Antioxidant Capacity

  2011cited by this paper
• The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus

  2011cited by this paper
• Zinc status in HIV infected Ugandan children aged 1-5 years: a cross sectional baseline survey

  2010cited by this paper
• Cofactors for Low Serum Albumin Levels Among HIV-Infected Individuals in Southern India

  2009cited by this paper
• Enhanced Oxidative Stress Markers and Antioxidant Imbalance in HIV Infection and AIDS Patients

  2009cited by this paper
• Pharmacological and Clinical Aspects of Heme Oxygenase

  2008cited by this paper
• High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters

  2006cited by this paper
• Vitamins C and E in adolescents and young adults with HIV infection.

  2006cited by this paper
• The effect of different combination therapies on oxidative stress markers in HIV infected patients in cameroon

  2006cited by this paper
• Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension.

  2005cited by this paper
• α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability

  2005cited by this paper
• A randomized trial of multivitamin supplements and HIV disease progression and mortality.

  2004cited by this paper
• A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok

  2003cited by this paper
• Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV‐infected subjects

  1998cited by this paper
• Effect of the Antioxidants Selenium and Beta-carotene on HIV-related Endothelium Dysfunction

  1998cited by this paper
• Glutathione deficiency is associated with impaired survival in HIV disease.

  1997cited by this paper
• Hyperuricemia and progression of HIV disease.

  1996cited by this paper
• Glutathione Inhibits HIV Replication by Acting at Late Stages of the Virus Life Cycle

  1996cited by this paper
• Intracellular glutathione as a possible direct blocker of HIV type 1 reverse transcription.

  1996cited by this paper
• Relationship of plasma malondialdehyde, vitamin E and antioxidant micronutrients to human immunodeficiency virus-1 seropositivity.

  1994cited by this paper
• The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus

  1992cited by this paper
• Lipid peroxidation in human immunodeficiency virus infection.

  1992cited by this paper
• Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine.

  1991cited by this paper
• Hypouricemia in acquired immunodeficiency syndrome.

  1990cited by this paper
• Systemic glutathione deficiency in symptom-free HIV-seropositive individuals.

  1989cited by this paper
• Increased production of malondialdehyde in patients with HIV infection.

  1988cited by this paper
• Bilirubin is an antioxidant of possible physiological importance.

  1987cited by this paper

• PON-1 and PON-2 Polymorphisms and PON-1 Paraoxonase Activity in People Living with HIV-1

  2025cites this paper
• Effect of Antiretroviral Therapy and Vitamin E Supplementation on Total Antioxidant Capacity in Children Living with HIV

  2025cites this paper
• Evidence of vitamin D deficiency in mediating disease progression among people living with human immunodeficiency virus: a narrative review

  2025cites this paper
• Oxidative Stress in People Living With HIV: Are Diverse Supplement Sources the Solution?

  2025cites this paper
• Occupational cancer risk surveillance in HIV-infected individuals exposed to chemicals: Role of p53 molecular marker

  2024cites this paper
• Methanol Crude Peel Extract of P. granatum Prevents Oxidative Damage in Kidneys of Rats Exposed to Highly Active Antiretroviral Therapy

  2024cites this paper
• Hepatoprotective effect of methanol fruit extract of Punica granatum L in highly active antiretroviral therapy-induced toxicity in Wistar rats

  2024cites this paper
• Increased cancer risk in HIV-infected individuals occupationally exposed to chemicals: Depression of p53 as the key driver

  2024cites this paper
• Manipulation of Oxidative Stress Responses by Non-Thermal Plasma to Treat Herpes Simplex Virus Type 1 Infection and Disease

  2023cites this paper
• A cross-sectional study to correlate antioxidant enzymes, oxidative stress and inflammation with prevalence of hypertension.

  2022cites this paper
• Активность реакций липопероксидации – антиоксидантной защиты у больных с ВИЧ-инфекцией (обзор)

  2021cites this paper
• Pattern of Plasma Lipid Profile among HIV Positive Patients on Anti-Retroviral Therapy

  2021cites this paper
• Lipid peroxidation, serum iron and some antioxidants activities in pregnant women infected with HIV and malaria

  2021cites this paper
• Emerging Role for Ferroptosis in Infectious Diseases.

  2021cites this paper
• Salivary Antioxidant and Oxidative Stress Marker Levels in HIV-Positive Individuals.

  2019cites this paper
• Nephrotoxicity and highly active antiretroviral therapy: Mitigating action of Momordica charantia

  2018cites this paper